key: cord-0263408-dj9fsuf4
authors: Bourgade, Karine; Frost, Eric H.; Dupuis, Gilles; Witkowski, Jacek M.; Laurent, Benoit; Calmettes, Charles; Ramassamy, Charles; Desroches, Mathieu; Rodrigues, Serafim; Fülöp, Tamás
title: Interaction mechanism between the HSV-1 glycoprotein B and the antimicrobial peptide Amyloid-β
date: 2022-02-19
journal: bioRxiv
DOI: 10.1101/2022.02.17.480815
sha: 05f53cdd6cde26bebacd9839ab70711226d0a785
doc_id: 263408
cord_uid: dj9fsuf4

Unravelling the mystery of Alzheimer’s Disease (AD) requires urgent resolution given the worldwide increase of the aging population. There is a growing concern that the current leading AD hypothesis, the amyloid cascade hypothesis, does not stand up to validation with respect to emerging new data. Indeed, several paradoxes are being discussed in the literature, for instance, both the deposition of the Amyloid-Beta peptide (Aβ) and the intracellular neurofibrillary tangles (NFTs) could occur within the brain without any cognitive pathology. Thus, these paradoxes suggest that something more fundamental is at play in the onset of the disease and other key and related pathomechanisms have to be investigated. The present study follows our previous investigations on the infectious hypothesis, which posits that some pathogens are linked to late onset AD. Our studies also build upon the shattering finding that Aβ is a powerful antimicrobial agent capable of inhibiting pathogens as observed in in vitro experiments. Herein, we ask what are the molecular mechanisms in play when Aβ neutralizes infectious pathogens? To answer this question, we probed at nanoscale lengths with FRET (Förster Resonance Energy Transfer), the interaction between Aβ peptides and glycoprotein B (responsible of virus-cell binding) within the HSV-1 virion. We concluded that there is indeed a close interaction, likely nonspecific or semi-specific, between the two types of molecules, which participate in virus neutralization.

Alzheimer's disease (AD) is the leading cause of dementia in the world, mainly due to the 47 kinetics of Aβ42 peptides aggregation and to a lesser extent that of Aβ40 peptides. The authors 96 have demonstrated an interaction between amyloid fibrils and the viral surface at different 97 stages of maturation via early protofibrillar intermediates. They also observed that HSV-1 98 infection led to increased accumulation of amyloid plaques in a mouse model of AD. In their 99 discussion, the authors try to reconcile the antimicrobial characteristics and the virus induced 100 nucleation process, leading to amyloid plaques. Certainly, this is not mutually exclusive as we 101 have shown that, at the beginning, the Aβ42 peptide secreted by cells is antimicrobial but as the 102 infection is progressing, it becomes pathogenic, by the virtue of the process described by Ezzat 103 et al. This reminds us of the capacity of bacteria to form biofilm which mimic plaques and the 104 fact that biofilms have already been demonstrated in AD (Miklossy, 2016) . These studies focus 105 only on the putative pathogenic interaction of HSV-1 and Aβ42 peptides, resulting in amyloid 106 plaque formation, rather than the antimicrobial interaction of Aβ42 against HSV-1. Indeed, 107 these studies have presented corona formation as an essential step in the viral infection. 108

We have demonstrated earlier that the Aβ peptide, as antimicrobial peptide, prevents 109 HSV-1 infection (Bourgade et al., 2015 (Bourgade et al., , 2016 . Indeed, we have demonstrated that Aβ peptides 110 addition in the culture media before or at the same time as HSV-1, decreases virus infectivity, 111 while adding Aβ peptides when HSV-1 has already entered the neurons, show no effects 112 (Bourgade et al., 2015) . Moreover, HSV-1-infected neurons supernatants, when added to new 113 neuronal cultures, were also able to inhibit infection by HSV-1, presumably due to induced 114 production of Aβ (Bourgade et al., 2016) . This accumulating evidence has led us to ask about 115 the molecular mechanisms of actions of Aβ peptides against AD pathogens. 116

Taking these data into consideration, it appears highly important to explore the currently 117 unknown mechanism whereby Aβ peptides render HSV-1 non-infectious. This potential gB-Aβ 118 peptides interaction could also be extended to other enveloped viruses, as well as peptides, and could represent a threshold when it becomes inefficient and pathological. Thus, the aim of the 120 present study was to gather more experimental data to determine the antiviral mechanism of Aβ 121 peptides against HSV-1 virus.

The amino acid sequence alignment between HSV-1 gB and Aβ42 was performed using 126 the PyMol software after having depicted the 3D structure of HSV-1-gB and Aβ42 peptide Statistical analysis was performed using two-tailed unpaired T-test.

We first depict the 3D structure of HSV-1-gB and Aβ42 peptides (Fig. 1A) . Sequence 164 homology was observed between the viral gB protein and Aβ42 be expected when virus is tested alone or if the gB-GFP was more than 10 nm from the red dye 182 linked to Aβ42 peptides. If red fluorescence is measured in the channel with excitation at 440 183 nm (which does not efficiently excite red fluorophores) and emission at 660 nm, then GFP has 184 transferred its energy to HiLyteFluor-555, which can then emit giving values that are high on 185 red axis and low on the green axis because the green fluorescence has been quenched by transfer to the red fluorophore. The observed values are presented in Fig. 2 and then analyzed 187 statistically in Table 1 . 188

Data showed that the green fluorescence emitted by HSV-1-gB-GFP alone (7,18 ± 0,94 189 AU) was significantly higher than that emitted by the HSV-1-gB-GFP/Aβ42-HiLyteFluor-555 190 mix (4,41 ± 0,35 AU) (Table 1) , whereas the mix gave much higher fluorescence in the red 191 channel than the virus alone did. Indeed, the ratio of red fluorescence divided by green 192 fluorescence was superior to 1 for the HSV-1-gB-GFP/Aβ42-HiLyteFluor-555 mix, but inferior 193 to 1 for HSV-1-gB-GFP alone. These results are consistent with FRET. We also observed that 194 when HSV-1-gB-GFP was pre-treated with NP40 prior to mixing or when blocking antibodies 195 directed against Aβ (α-Aβ42-Ab) were pre-mixed with Aβ42-HiLyteFluor-555, then mean 196 green fluorescence values were 7,22 ± 0,47 AU and 6,58 ± 0,77 AU respectively, which are 197 significantly different from the mean values without pre-treatment (4,41 ± 0,35 AU), and 198 similar to those obtained for HSV-1gB-GFP alone. Furthermore, the ratio of red to green 199 fluorescence also decreased to values lower than 1 in the pre-treated samples. These latter 200 results corresponded to an absence of FRET. We concluded that FRET took place between the two fluorochromes, indicating that they are at 208 a distance less than or equal to 10 nM (Broussard et al., 2013) . Considering the proximity of 209 shown that it is also able to insert into lipid bilayers and form pores (Lemkul and Bevan, 2013; 227 Kagan et al., 2012) . It is also possible that the Aβ42-HiLyteFluor-555 has integrated the corona 228 as it has been shown to be present, but this would not explain the loss of infectivity. Indeed, it 229 has been postulated that HSV-1 must be surrounded by a corona to be infectious. 230

Our results shown here seem to confirm (at least in vitro) that the Aβ acts as an 

Dynamic 269 organization of Herpesvirus glycoproteins on the viral envelope revealed by super-270 resolution microscopy

Differential protein partitioning within the 272 herpesvirus tegument and envelope underlies a complex and variable virion architecture

Amyloid peptides display protective activity against the human Alzheimer's disease-277 associated herpes simplex virus-1

Protective 279 Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal 280

Anti-Viral Properties of Amyloid-β peptides

PyMod: sequence similarity searches, multiple 284 sequence-structure alignments, and homology modeling within PyMOL

Fluorescence resonance energy transfer 287 microscopy as demonstrated by measuring the activation of the serine/threonine kinase 288

Herpes simplex virus dances with 290 amyloid precursor protein while exiting the cell

The viral protein corona directs viral pathogenesis 292 and amyloid aggregation

Die presbyophrene demenz, deren anatomische grundlage und klinische abgrenzung

Can an Infection Hypothesis Explain the Beta 296

Amyloid Hypothesis of Alzheimer's Disease? Front Aging Neurosci

Time of COVID-19: Opportunities and Innovations in Antivirals from Nature

The 301 Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit

Angiotensin-Converting Enzyme 2

SARS-CoV-2 spike protein interactions with amyloidogenic proteins: 304 Potential clues to neurodegeneration

Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease

Antimicrobial properties of amyloid peptides

The role of the multifunctional peptide LL-37 in host defense

Inflammation 313 as a central mechanism in Alzheimer's disease